EPS Bio Technology Corp. (4183.TWO)
TWD 22.65
(0.22%)
TWD 22.65
(0.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 55.17 Million | 4.99 Million | 32.08 Million | 79.9 Million | 21.84 Million |
| Net Income | 26.45 Million | 27.45 Million | 23.52 Million | 40.07 Million | 18.43 Million |
| Depreciation & Amortization | 15.49 Million | 17.3 Million | 18.58 Million | 17.83 Million | 15.66 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 12.81 Million | -29.94 Million | -13.96 Million | 21.65 Million | -19.07 Million |
| Other non-cash items | -442 Thousand | 1.91 Million | 2.09 Million | 1.75 Million | 6.81 Million |
| Investing Cash Flow | -9.47 Million | -14.91 Million | -12.13 Million | -6.98 Million | -17.14 Million |
| Investments in PPE | -9.47 Million | -14.95 Million | -12.13 Million | -6.98 Million | -15.15 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | 35 Thousand | - | - | - |
| Financing Cash Flow | -28.91 Million | -22.59 Million | -34.01 Million | -22.02 Million | -21.83 Million |
| Debt repayment | -2.5 Million | -2.51 Million | -2.49 Million | -2.45 Million | -2.35 Million |
| Dividends payments | -23.32 Million | -16.66 Million | -28.56 Million | -16.66 Million | -16.66 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -3.08 Million | - | - | - | -2.82 Million |
| Accounts receivables | -17.7 Million | - | - | - | -32.24 Million |
| Accounts payables | 16.41 Million | - | - | - | -8.52 Million |
| Inventory | 10.86 Million | -4.88 Million | -35.45 Million | -2.04 Million | 14.24 Million |
| Other working capital | 19.66 Million | - | - | - | 7.45 Million |
| Cash at beginning of period | 178.65 Million | 203.42 Million | 221.87 Million | 175.78 Million | 194.8 Million |
| Cash at end of period | 195.28 Million | 178.65 Million | 203.42 Million | 221.87 Million | 175.78 Million |
| Capital Expenditure | -9.47 Million | -14.95 Million | -12.13 Million | -6.98 Million | -15.15 Million |
| Effect of forex changes on cash | -151 Thousand | 7.74 Million | -4.38 Million | -4.8 Million | - |
| Net cash flow / Change in cash | 16.63 Million | -24.76 Million | -18.45 Million | 46.09 Million | -19.01 Million |
| Free Cash Flow | 45.69 Million | -9.95 Million | 19.94 Million | 72.92 Million | 6.69 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 8.12 Million | 12.78 Million | 26.45 Million | 5.15 Million | 12.97 Million | 5.21 Million |
| Depreciation & Amortization | 3.91 Million | 3.52 Million | 15.49 Million | 3.66 Million | 3.9 Million | 3.95 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -23.14 Million | -3.74 Million | 12.81 Million | 4.05 Million | 4.61 Million | -2.14 Million |
| Other non-cash items | -544 Thousand | 72 Thousand | -442 Thousand | -382 Thousand | 127 Thousand | -309 Thousand |
| Investing Cash Flow | -2.82 Million | -7.83 Million | -9.47 Million | -1.12 Million | -6.84 Million | -1.02 Million |
| Investments in PPE | -2.82 Million | -7.83 Million | -9.47 Million | -1.12 Million | -6.84 Million | -1.02 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -100 Thousand | - | - | - | - | - |
| Financing Cash Flow | -1.41 Million | -1.41 Million | -28.91 Million | -1.4 Million | -24.72 Million | -1.39 Million |
| Debt repayment | -634 Thousand | -632 Thousand | -2.5 Million | -631 Thousand | -627 Thousand | -625 Thousand |
| Dividends payments | - | - | -23.32 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -782 Thousand | - | - | - | - | - |
| Accounts receivables | -62.48 Million | - | - | - | - | - |
| Accounts payables | 39.22 Million | - | - | - | - | - |
| Inventory | -177 Thousand | 2.06 Million | 10.86 Million | 34.58 Million | -26.13 Million | 4.45 Million |
| Other working capital | 297 Thousand | - | - | - | - | - |
| Cash at beginning of period | 194.13 Million | 195.28 Million | 178.65 Million | 179.1 Million | 193.49 Million | 190.78 Million |
| Cash at end of period | 177.74 Million | 194.13 Million | 195.28 Million | 195.28 Million | 179.1 Million | 193.49 Million |
| Capital Expenditure | -2.82 Million | -7.83 Million | -9.47 Million | -1.12 Million | -6.84 Million | -1.02 Million |
| Effect of forex changes on cash | 1.21 Million | 3.84 Million | -151 Thousand | -2.84 Million | 1.9 Million | 1.07 Million |
| Net cash flow / Change in cash | -16.38 Million | -1.15 Million | 16.63 Million | 16.17 Million | -14.38 Million | 2.7 Million |
| Free Cash Flow | -16.18 Million | -3.59 Million | 45.69 Million | 20.42 Million | 8.42 Million | 3.02 Million |
3598
AIMLF
TNPETRO
SIG
0RQH
XCLL